Under the deal, Peptris Technologies is licensing PEPR124 (RT001), a preclinical-stage drug, to Revio Therapeutics for ...

Peptris Technologies out-licenses India’s first AI discovered drug candidate to Revio Therapeutics: Our Bureau, Bengaluru Monday, March 17, 2025, 12:50 Hrs [IST] Peptris Technol ...

Preservation of Skeletal Muscle Function Shown Over 3 Years Resulting in 52% Slowing of Disease----Data Presented at the 2025 Muscular ...

Roche to present latest scientific advancements from its neuromuscular portfolio at Muscular Dystrophy Association 2025 conference: Basel Tuesday, March 18, 2025, 11:00 Hrs [IST] ...

From STAT’s Andrew Joseph: AstraZeneca said this morning it was buying the Belgian cell therapy company EsoBiotec for $425 ...

The impact of Illinois Gov. JB Pritzker’s plan to eliminate a health insurance program for noncitizen immigrants ages 42 to ...

The competition between U.S. and Chinese biotech companies is particularly fierce in one field: CRISPR gene editing. Here are ...

Despite being born with malformed limbs and later giving birth to four children, Francisca avoided going to the doctor as ...

The growing number of Malaysians seeking help for mental health issues should not be viewed negatively, say mental health ...

Black mothers are three times as likely as white women to die in childbirth, and Black fetuses and infants die at rates far ...

Advancements in genome editing, particularly CRISPR, are reshaping precision biology, driving innovations in medicine, agriculture, and synthetic biology.